Increasing incidence and prevalence of biochemically confirmed primary hyperparathyroidism in Stockholm, 2006-2020
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag162 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von David Thorsteinsson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm 171 76, Sweden. Hauptthemen laut MEDLINE: Hyperparathyroidism, Primary. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Serafimerlasarettet foundation, Region Stockholm FoUI.
Abstract (Originalsprache)
Context
Primary hyperparathyroidism (PHPT) prevalence appears to be rising, but substantial underdiagnosis persists. Accurate epidemiological data are needed, requiring population-based studies using strict biochemical criteria.
Objective
To determine incidence and prevalence of biochemically confirmed PHPT in Stockholm and characterize clinical recognition and surgical management.
Methods
This is a population-based healthcare cohort study using prespecified biochemical diagnostic algorithms in the Stockholm Region, Sweden, 2006-2020, using the Stockholm CREAtinine Measurements database which covers two-thirds of the adult population, including ≥90% of individuals ≥65 years. Adults aged ≥20 years with paired calcium and parathyroid hormone (PTH) measurements meeting biochemical criteria for PHPT were included. Individuals with estimated glomerular filtration rate ≤30 mL/min/1.73 m2, secondary hyperparathyroidism, or prior parathyroid surgery were excluded. Main outcome measures were the annual incidence rate and point prevalence of biochemically confirmed PHPT.
Results
Among 176 780 individuals contributing 578 227 PTH measurements, 10 190 patients fulfilling biochemical PHPT criteria were identified. Age- and sex-adjusted incidence rate increased from 2.81 (95% CI, 2.55-3.09) to 4.28 (95% CI, 3.98-4.59) per 10 000 person-years between 2009 and 2020, with the steepest increase among women aged ≥70 years. Prevalence increased from 0.35 to 4.76 per 1000 individuals. Median ionized calcium was 1.39 mmol/L. Clinical diagnosis of PHPT was documented in 5346 (52%) patients, of which 2800 (52%) underwent parathyroidectomy, with surgery rates stabilizing after 2013 at 4% to 5% annually.
Conclusion
Using a large healthcare database, we observed substantially increasing PHPT incidence and prevalence, predominantly in older individuals. Only 52% received clinical diagnosis, underscoring the need for studies evaluating the long-term clinical burden of undiagnosed PHPT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast, Endocrine Tumors and Sarcoma, Karolinska University Hospital, Stockholm 171 76, Sweden.
- Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm 171 76, Sweden.
- Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet, Stockholm 171 77, Sweden.
- Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 171 77, Sweden.
- Division of Nephrology, Department of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Stockholm 182 88, Sweden.
ORCID-Profile: David Thorsteinsson, Fredrik Granath, Robert Bränström, Jan Zedenius, Juan-Jesus Carrero, Inga-Lena Nilsson
Förderung
- Serafimerlasarettet foundation
- Region Stockholm FoUI
Zitieren
APA
Thorsteinsson, D., Granath, F., Bränström, R., Zedenius, J., Carrero, J. J., & Nilsson, I. L. (2026). Increasing incidence and prevalence of biochemically confirmed primary hyperparathyroidism in Stockholm, 2006-2020. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag162
Vancouver
Thorsteinsson D, Granath F, Bränström R, Zedenius J, Carrero JJ, Nilsson IL. Increasing incidence and prevalence of biochemically confirmed primary hyperparathyroidism in Stockholm, 2006-2020. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag162
BibTeX
@article{Thorsteinsson2026,
author = {Thorsteinsson, David and Granath, Fredrik and Bränström, Robert and Zedenius, Jan and Carrero, Juan-Jesus and Nilsson, Inga-Lena},
title = {Increasing incidence and prevalence of biochemically confirmed primary hyperparathyroidism in Stockholm, 2006-2020},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag162}
}
EUVIMED